Evidence map›Paper›PMID 42871702›Full record

ArticleAME case reports2026

Thyroid disease-related false-negative ultrasonography and 99mTc-MIBI scintigraphy in primary hyperparathyroidism: a case report and literature review.

Chenxuan Liu, Bo Xu

Abstract readCase Reports
In one paragraph

Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chenxuan LiuThe First Clinical Medical College, Guangdong Medical University, Zhanjiang, China.
Bo XuDepartment of Thyroid and Breast Surgery, Guangzhou First People's Hospital, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple gland disease associated with primary hyperparathyroidism (PHPT) are relatively rare, and those combined with underlying thyroid diseases are even rarer. This study aimed to investigate the approaches to preoperative localization and enumeration of lesions, as well as the determination of surgical endpoints in such patients. Case Description: A female patient was admitted due to "elevated serum calcium detected for more than 20 days", with a past medical history of hyperthyroidism and Hashimoto's thyroiditis. Neck ultrasound only suggested a single-gland lesion, and 99mTc-MIBI scintigraphy demonstrated unremarkable findings. Subsequent contrast-enhanced computed tomography (CT) revealed enlarged parathyroid glands posterior to both lobes of the thyroid gland. Preoperative diagnosis was PHPT with suspected multiglandular disease. Bilateral cervical exploration and parathyroidectomy were performed. Intraoperatively, two enlarged parathyroid glands were identified, located posterior to the upper pole of the left thyroid lobe and in the right central compartment respectively. Postoperative pathology confirmed nodular hyperplasia of the parathyroid glands in both lesions. Conclusions: In patients with multiple gland disease associated with PHPT complicated with underlying thyroid diseases, identification of the location and number of lesions is more challenging. Additional imaging examinations should be performed on the basis of first-line tests to clarify the lesions. To avoid missed lesions, more stringent criteria should be applied for determining surgical endpoints beyond the traditional Miami criteria. This case report will provide valuable clinical experience for the diagnosis and treatment of similar cases in the future.

Indexed as

case reportfalse negativehyperthyroidismimaging examinationPrimary hyperparathyroidism (PHPT)

Identifiers

PMID42871702
PMCPMC13659134

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.